Biocon inks deal with Tabuk Pharma to commercialize GLP -1 products in Middle East 0 27.09.2024 08:33 Business Standard Biocon said that it has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialize its GLP-1 products for treating diabetes and chronic weight management, in select countries of the Middle East. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
